五种酶组织化学方洁显示大鼠海马微血管的比较

本文对１０例成年Ｗｉｓｔａｒ大鼠海马,应用过氧化物酶二氨基联苯胺（ＤＡＢ）法、碱性磷酸酶（ＡＩＰ）、镁离子激活的三磷酸腺苷酶（Ｍｇ（２＋）－ＡＴＰａｓｅ）、钙离子激活的三磷酸腺昔酶（Ｃａ（２＋）－ＡＴＰａｓｅ）和５’－核苷酸酶（５’－Ｎａｓｅ）等酶组织化学方法显示其微血管,并应用体视学方法测算,比较上述方法显示微血管的效果,结果表明：ＤＡＢ法显示微血管的效果最好,ＡＩＰ法次之,Ｍｇ（２＋）－ＡＴ－Ｐａｓｅ法再次之。大鼠海马微血管Ｃａ（２＋）－ＡＴＰａｓｅ呈弱阳性,５‘－Ｎａｓｅ呈阴性。ＤＡＢ法和Ｍｇ（２＋）－ＡＴＰａｓｅ法分别适宜作微血管长度密度和血管直径的定量分析。     

低氧、血管紧张素Ⅱ对肺内小动脉平滑肌细胞膜Ca2 ┐ATPase活力的影响

本课题观察了低氧及血管紧张素Ⅱ（ａｎｇｉｏｔｅｎｓｉｎⅡ,ＡｎｇⅡ）对分离培养家兔肺内小动脉平滑肌细胞（ＰＡＳＭ－Ｃｓ）膜Ｃａ２＋－ＡＴＰａｓｅ活力的影响,同时用钙通道阻断剂维拉帕米（ｖｅｒａｐａｍｉｌ,ＶＰ）进行干预,进一步了解细胞内钙与Ｃａ２＋－ＡＴＰａｓｅ活力的关系。结果表明：ＰＡＳＭＣｓ膜Ｃａ２＋－ＡＴＰａｓｅ活力对低氧具有短暂的耐受性,随低氧时间延长,Ｃａ２＋－ＡＴＰａｓｅ活力呈时间依赖性抑制;低氧、ＡＮＧⅡ均能抑制Ｃａ２＋－ＡＴＰａｓｅ活力（Ｐ＜０．０１）低氧＋ＡⅡ对Ｃａ２＋－ＡＴＰａｓｅ活力的抑制具叠加效应（Ｐ＜０．０５）;ＶＰ可逆转低氧、ＡｎｇⅡ、低氧＋ＡｎｇⅡ对Ｃａ２＋－ＡＴＰａｓｅ活力的抑制（Ｐ＜０．０１）。结果提示：低氧,ＡＮＧⅡ可通过抑制肺血管平滑肌细胞膜Ｃａ２＋－ＡＴＰａｓｅ活力而可能削弱肺血管平滑肌舒张功能也可能是低氧性肺动脉高压（ＨＰＨ）形成的原因之一。     

抗寒锻炼对冬小麦幼苗质膜Ca^2＋—ATPase的稳定作用

通过氯化铈（ＣｅＣｌ３）沉淀的电镜细胞化学方法,观察了抗寒锻炼对冬小麦（ＴｒｉｔｉｃｕｍａｅｓｔｉｖｕｍＬ．）幼苗质膜Ｃａ２＋ＡＴＰａｓｅ的稳定作用,主要结果是：（１）正常温度（２０℃）下生长的冬小麦幼苗（未经抗寒锻炼）,其质膜上有很强的Ｃａ２＋ＡＴＰａｓｅ活性反应;当经过－９℃３ｈ的低温处理后,质膜的Ｃａ２＋ＡＴＰａｓｅ活性明显降低;在处理１２ｈ后,质膜的Ｃａ２＋ＡＴＰａｓｅ活性进一步降低;当处理时间延长到２４ｈ,质膜的Ｃａ２＋ＡＴＰａｓｅ完全失活,同时细胞的超微结构受到破坏。（２）冬小麦幼苗在２℃低温下锻炼１５ｄ后,其质膜的Ｃａ２＋ＡＴＰａｓｅ活性高于未经抗寒锻炼的小麦幼苗。抗寒锻炼后的小麦幼苗在－９℃处理３ｈ后,质膜的Ｃａ２＋ＡＴＰａｓｅ活性与低温处理前相比无明显降低;经低温处理１２ｈ,质膜仍保持较高的Ｃａ２＋ＡＴＰａｓｅ活性,较同样低温处理（－９℃,１２ｈ）但未经抗寒锻炼的幼苗高;当－９℃低温处理２４ｈ后,质膜上仍可观察到Ｃａ２＋ＡＴＰａｓｅ的活性反应,而且细胞的超微结构也未受到破坏。结果表明,抗寒锻炼可提高冬小麦幼苗质膜Ｃａ２＋ＡＴＰａｓｅ在低温下的稳定性     

实验性肝硬化部分肝切除后肝组织学及组织化学变化的研究

四氯化碳所致肝硬化的大白鼠,进行７０％和３０％肝脏切除,于术后４８小时、１周、２周分别取剩余肝脏观察肝的组织化学变化,包括ＤＮＡ（脱氧核糖核酸）,ｈｉｓｔｏｎｅ（组蛋白）、ＲＮＡ（核糖核酸）、ＳＤＨ（琥珀酸脱氢酶）、Ｇ－６－Ｐａｓｅ（葡萄糖－６－磷酸酶）、Ｍｇ－ＡＴＰａｓｅ（镁激活三磷酸腺苷酶）、ＣｈＥ（胆碱酯酶）、ＡＫＰ（碱性磷酸酶）、ＡＣＰ（酸性磷酸酶）,ＰＡＳ（糖原）反应。其中肝硬化切除３０％肝脏的动物,术后４８小时再生肝细胞活跃,肝脏ＤＮＡ、ｈｉｓｔｏｎｅ、ＳＤＨ、Ｇ－６－ｐａｓｅ、ＡＴＰａｓｅ活性及反应明显增高;而ＣｈＥ活性及ＰＡＳ反应等显著减弱。     

小鼠胸腺哺育细胞内淋巴细胞碱性磷酸酶电镜观察

碱性磷酸酶（ａｌｋａｌｉｎｅｐｈｏｓｐｈａｔａｓｅ,ＡＬＰ）是研究Ｔ淋巴细胞分裂分化的标记之一。胸腺内淋巴母细胞具有膜性ＡＬＰ。本文采用ＡＬＰ超微结构细胞化学方法,探讨小鼠胸腺哺育细胞（Ｔｈｙｍｉｃｎｕｒｓｅｃｅｌ,ＴＮＣ）内淋巴细胞（ＴＮＣ－Ｌ）ＡＬＰ的活性分布。观察结果,２０％的ＴＮＣ内有少数淋巴细胞呈阳性反应,而ＴＮＣ外游离的淋巴细胞均为ＡＬＰ阴性反应。结果表明,部分ＴＮＣ内含有少量淋巴母细胞亚群,ＴＮＣ是Ｔ淋巴细胞分裂分化的微环境之一     

国人睾丸、附睾和输精管的水解酶的组织化学观察

本文报导国人睾丸、附睾和输精管的ＮＳＥ,ＡＣｈＥ,ＣｈＥ,ＡＬＰ,ＡＣＰ,５＇－Ｎａｓｅ,Ｇ－６－Ｐａｓｅ,β－ＧＡ,β－ＧＲ,ＡＰ－Ｍ,ＡＴＰａｓｅ和ＴＰＰａｓｅ水解酶的组织化学活性、结果显示：睾丸曲细精管的ＡＬＰ,５＇－Ｎａｓｅ和ＡＴＰａｓｅ;睾丸间质细胞的ＮＳＥ,ＡＬＰ,ＡＴＰａｓｅ和ＡＣＰ;睾丸间质中的ＮＳＥ,ＡＬＰ和ＡＴ－Ｐａｓｃ;睾丸输出小管和附睾管上皮的ＮＳＥ,ＡＬＰ,ＡＣＰ,５’－Ｎａｓｅ,β－ＧＡ,β－ＧＲ,ＡＴＰａｓｅ和Ｔｐｐａｓｅ;附睾头部间质中的ＮＳＥ,ＡＣｈＥ,ＡＬＰ,和ＡＴＰａｓｅ;输精管上皮细胞的ＡＴＰａｓｅ的酶活性均呈强阳性或极强阳性。说明人类睾丸、附睾和输精管含有丰富的水解酶,尤其是附睾头部的输出小管、附睾管和头质均含有种类多活性高的水解酶,在精子的功能成熟上起了重要的作用,提示其可能作为生育与不育诊治中的重要指标。     

骤冷与饥饿对小鼠肝脏影响的实验研究

为探讨饥饿及饥饿与骤冷对动物肝脏的影响,本实验用健康昆明种小鼠２５只,随机分成正常组５只,饥饿组１０只,饥饿后再予冷刺激组１０只（下称骤冷组）。采用组织化学及酶组织化学方法观察糖原（ＰＡＳ反应）、ＳＤＨ（琥珀酸脱氢酶）,ＬＤＨ（乳酸脱氢酶）,ＣｈＥ（胆碱酯酶）、Ｍｇ２＋－ＡＴＰａｓｅ（镁激活三磷酸腺苷酶）,ＡＣＰ（酸性磷酸酶）。结果提示：饥饿时肝脏ＰＡＳ反应,ＳＤＨ,Ｍｇ２＋－ＡＴＰａｓｅ、ＣｈＥ活性显著下降,而ＡＣＰ活性明显增强;饥饿后骤冷时ＰＡＳ（反应）、ＳＤＨ、ＣｈＥ更显著下降,而ＡＣＰ及Ｍｇ２＋－ＡＴＰａｓｅ活性反而增强。     

DOPE、DOPC对重组去脂肌质网Ca~(2+)-ATPase活力和构象的影响

经磷脂酶Ａ２ 去脂的肌质网Ｃａ２ ＋ － ＡＴＰａｓｅ 重组于不同比例的二油酰磷脂酰胆碱（Ｄｉｏｌｅｏｙｌｐｈｏｐｈａｔｉｄｙｌｃｈｏｌｉｎｅ,ＤＯＰＣ） 和二油酰磷脂酰乙醇胺（Ｄｉｏｌｅｏｙｌｐｈｏｐｈａｔｉｄｙｌｅｔｈａｎｏｌａｍｉｎｅ,ＤＯＰＥ） 形成脂酶体,研究了不同磷脂环境中Ｃａ２ ＋ － ＡＴＰａｓｅ 的ＡＴＰ 水解和Ｃａ２ ＋ 转运活力。结果表明,ＤＯＰＣ 和ＤＯＰＥ 分别有利于ＡＴＰ 水解和Ｃａ２ ＋ 的转运,ＤＯＰＥ 可以增强Ｃａ２ ＋ － ＡＴＰａｓｅ 的ＡＴＰ水解和Ｃａ２ ＋ 转运之间的偶联效率。利用内源荧光、荧光淬灭及Ｆｏｒｓｔｅｒ 能量转移原理测定Ｃａ２ ＋ －ＡＴＰａｓｅ 相应的构象变化, 发现随着ＤＯＰＥ／ ＤＯＰＣ 比例的改变使Ｃａ２ ＋ － ＡＴＰａｓｅ 构象发生相应的变化。     

稀土离子对CaM及Ca2+-Mg2+-ATPase活力及CD研究

研究了稀土离子（Ｌｎ３＋）对钙调蛋白（ＣａＭ）调控的Ｃａ２＋－Ｍｇ２＋－ＡＴＰａｓｅ的活力影响。结果表明,在ＣａＭ和Ｃａ２＋－Ｍｇ２＋－ＡＴＰａｓｅ的体系中,一些Ｌｎ３＋（Ｌａ３＋、Ｇｄ３＋）对由ＣａＭ调节的Ｃａ２＋－Ｍｇ２＋－ＡＴＰａｓｅ的活力影响呈现双相效应,即Ｌｎ３＋在低浓度时,能提高激活Ｃａ２＋－Ｍｇ２＋－ＡＴＰａｓｅ的水解活力;在高浓度时,则抑制ＣａＭ调节Ｃａ２＋－Ｍｇ２＋－ＡＴＰａｓｅ活力的能力;少数Ｌｎ３＋（Ｓｍ３＋）仅表现出抑制效应。在无ＣａＭ的Ｃａ２＋－Ｍｇ２＋－ＡＴＰａｓｅ体系中,高浓度的Ｌｎ３＋抑制Ｃａ２＋－Ｍｇ２＋－ＡＴＰａｓｅ的基础活力。结合圆二色（ＣＤ）谱信息对Ｌｎ３＋和ＣａＭ相互作用的分子机制进行了初步的探讨。     

不同频率电刺激膈神经导致膈肌肌浆网Ca~(2 )-ATPase和Ca~(2 )释放-摄取动力学改变

研究不同频率慢性电刺激（ＣＥＳ）后兔膈肌肌浆网（ＳＲ）Ｃａ２＋－ＡＴＰａｓｅ活性以及ＳＲ Ｃａ２＋摄取－释放动力学对不同频率ＣＥＳ的适应性变化。建立不同频率ＣＥＳ组;用定磷法测定ＳＲ Ｃａ２＋－ＡＴＰａｓｅ活性;用Ｆｕｒａ－２荧光法测定ＳＲ　Ｃａ２＋摄取－释放动力学。与对照组比较,慢性低频电刺激１０ Ｈｚ和２０Ｈｚ组的ＳＲ　Ｃａ２＋－ＡＴＰａｓｅ活性明显降低（Ｐ＜０．０１）,Ｃａ２＋释放－摄取动力学也显著降低（Ｐ＜０．０１）;慢性高频电刺激５０ Ｈｚ和１００Ｈｚ组的ＳＲ Ｃａ２＋－ＡＴＰａｓｅ活性则显著升高（Ｐ＜０．０１）,Ｃａ２＋释放－摄取动力学亦明显升高（Ｐ＜０．０１）。实验提示,ＣＥＳ后不同频率ＣＥＳ导致膈肌ＳＲＣａ２＋－ＡＴＰａｓｅ、Ｃａ２＋摄取－释放动力学产生不同的适应性变化;对不同功能状态的膈肌应用不同频谱的慢性电刺激可能具有重要的临床意义。     

牛蛙消化道黏膜5种酶的分布

目的研究牛蛙(Rana catesbeinana)消化道黏膜碱性磷酸酶(ALP)、酸性磷酸酶(ACP)、ATP酶、酯酶和脂酶的分布。方法在消化道的8个部位取材,采用冰冻切片技术和酶的组织化学方法。结果 ALP主要分布于十二指肠、空肠和回肠,胃中酶反应呈弱阳性。ACP主要分布于胃中,食道和肠道酶反应呈弱阳性。ATP酶在消化道各部位均有较多分布,十二指肠、空肠和回肠显著较多,胃各部位其次。酯酶和脂酶均主要分布于肠道,胃各部位其次。结论牛蛙消化道黏膜酶的分布同其它动物有相似之处,也有其自身特点。十二指肠、空肠和回肠是牛蛙的主要消化吸收部位。     

Comparison of the intratumor DNA ploidy distribution pattern between differentiated and undifferentiated gastric carcinoma

OBJECTIVE: To compare the differences in intratumor DNA ploidy distribution pattern between differentiated and undifferentiated carcinoma of the stomach. STUDY DESIGN: Two hundred five cases of surgically resected gastric carcinoma were studied, comprising 125 differentiated and 80 undifferentiated carcinomas. DNA ploidy was determined by means of flow cytometry in stepwise sections of the entire tumor. The intratumor DNA ploidy distribution pattern was compared between these two histologic types. RESULTS: Differentiated carcinomas comprised 35 cases of predominantly diploid (28%) and 90 cases of predominantly aneuploid (72%) tumors, while undifferentiated carcinomas comprised 46 cases of predominantly diploid (57.5%) and 34 cases of predominantly aneuploid (42.5%) (P < .01). The frequency of cases showing predominantly aneuploidy among the differentiated carcinomas was significantly higher than among the undifferentiated carcinomas at stages IA and IIIA. The rate of cases showing heterogeneity was lower among the early-stage cases than among the advanced-stage cases in both histologic types. Among the differentiated carcinomas, there were 22 cases that had more than six DNA stemlines in each tumor, whereas among undifferentiated carcinomas, there were six such cases (P < .05). CONCLUSION: There were more cases with high malignant potential among the differentiated carcinoma cases than among the undifferentiated carcinoma cases in the present series.     

Carcinoembryonic antigen gene and carcinoembryonic antigen expression in the liver metastasis of colorectal carcinoma.

The presence of the carcinoembryonic antigen (CEA) gene and CEA expression in the liver was tested to identify their possible roles in the liver metastasis of colorectal carcinoma. The CEA gene in the liver was identified by amplifying the CEA-specific N-terminal domain exon with digoxigenin-dUTP labeling in 16 colorectal carcinomas with liver metastases. Next, CEA expression was tested by immunostaining using the anti-CEA monoclonal antibody (T84.66, ATCC). Liver tissues from 13 stomach cancer patients and 12 colorectal cancer patients without liver metastasis were also tested as control groups. Three grades (<25%, 25-50%, and 50%< or =) were given according to the proportion of positive cells. The CEA gene was amplified in the metastatic tumor cells of the liver (2.6 +/- 0.2, mean grade +/- SEM) and their surrounding hepatocytes (1.5 +/- 0.2) in all cases. CEA expression was found in all metastatic tumor cells and 14 cases of the surrounding hepatocytes. Among the control groups, the CEA gene of the hepatocytes was found in 9 cases each of the colorectal and the stomach cancers that did not exhibit CEA expression. The level of serum CEA was related with the numbers and volume of liver metastases, but not with CEA expression in tumor cells and surrounding hepatocytes. The CEA gene in the metastatic tumor cells, not in the hepatocytes, was closely associated with CEA expression in the surrounding hepatocytes (p<0.01). Although the precise mechanism of CEA gene regulation in hepatocytes remains to be proven, the CEA gene in the metastatic tumor of the liver seems to affect CEA expression in the surrounding hepatocytes facilitating liver metastasis in colorectal carcinoma.     

MRP2 蛋白在食管鳞癌中的表达及其与化疗耐药的相关性

目的:探讨MRP2蛋白在食管鳞癌组织中的表达及其与食管癌化疗耐药的关系。方法:收集原发性食管鳞癌手术标本70例,采用免疫组织化学Envision法检测食管鳞癌组织及其癌旁组织中MRP2蛋白的表达情况,并采用MTT法检测食管鳞癌组织对临床常用化疗药物的敏感性,分析其表达与食管癌化疗耐药的关系。结果:70例食管鳞癌组织及其癌旁正常组织中的阳性表达率分别为58.6%及5.0%。MRP2蛋白在食管鳞癌组织中的阳性表达率明显高于癌旁正常食管组织(P<0.01)。食管鳞癌组织对环磷酰胺、5-氟尿嘧啶、吉西他滨、顺铂、卡铂、阿霉素、长春瑞滨、羟喜树碱等化疗药物的敏感性与其相应癌组织中MRP2表达明显相关(P<0.01)。结论:MRP2的表达与食管鳞癌对多种化疗药物耐药有较好的相关性,推测食管鳞癌组织中MRP2的高表达可能对化疗耐药性的发生发展具有促进作用。     

Terminal alpha1,4-linked N-acetylglucosamine in Helicobacter pylori-associated intestinal metaplasia of the human stomach and gastric carcinoma cell lines.

Helicobacter pylori (Hp) infection is associated with the development of gastric lesions including gastritis, intestinal metaplasia (IM), and gastric carcinoma. In humans, Hp is found almost exclusively in the foveolar epithelium of the gastric mucosa and rarely colonizes the deeper portions where mucous cells of the glands produce mucins with terminal alpha1,4-GlcNAc O-glycans. This structure exerts antimicrobial activity against Hp. The development of IM in the stomach is characterized by Hp clearance from the metaplastic glands and by major alterations in the expression of mucins and mucin-carbohydrates. The present work evaluated whether terminal alpha1,4-GlcNAc and sialyl-Tn antigen are implicated in the process of Hp clearance from metaplastic glands by analyzing the expression of these antigens in different types of IM-complete (n=12) and incomplete (n=8)-and in gastric cell lines. Terminal alpha1,4-GlcNAc was not detected in IM except in a single foci of one case, indicating that this structure is not implicated in the clearance of Hp from IM, in contrast to what is observed in normal gastric mucosa. None of the gastric carcinoma cell lines studied showed terminal alpha1,4-GlcNAc, suggesting that they do not display a gastric gland mucous cell phenotype and therefore are useful models for in vitro Hp studies. Finally, sialyl-Tn antigen colocalizes with MUC2 mucin and is present in all cases of complete and incomplete IM, suggesting that either or both can be implicated in Hp clearance from IM.     

酸性同工铁蛋白、p53在大肠腺癌和大肠腺瘤组织中的表达及其意义的探讨

采用抗人胎盘酸性同工铁蛋白单克隆抗体、ｐ５３ 单克隆抗体和免疫组化方法,分别对３２ 例大肠腺癌、３０ 例大肠腺瘤和３０ 例非肿瘤性大肠粘膜组织进行检测。结果是酸性同工铁蛋白在５３．１％ 的大肠腺癌和１６．６７％ 的大肠腺瘤中为阳性表达, 二者阳性率比较存在显著性差异 （Ｐ＜ ０．０５）, 在非肿瘤性大肠粘膜组织中全部为阴性; ｐ５３ 在４３．８％ 的大肠腺癌和１３．３％ 的大肠腺瘤中为阳性表达; 在大肠腺癌组织中, 酸性同工铁蛋白与ｐ５３ 的表达符合率为７１．９％ （同为阳性者为３４．４％ , 同为阴性者为３７．５％ ）, 经统计学检验酸性同工铁蛋白的表达与ｐ５３ 的表达具有显著的相关性; 在３０ 例大肠腺瘤组织中, 酸性同工铁蛋白与ｐ５３ 同为阳性表达者３ 例, 该３ 例组织均可见非典型增生的病理变化。本研究结果表明大肠癌细胞内存在酸性铁蛋白抗原, 这些酸性铁蛋白若释放到血液中可能是造成患者血清铁蛋白水平升高的主要原因之一; 另外还提示对大肠腺瘤患者进行ｐ５３ 和酸性同工铁蛋白的检测可能作为判断其早期癌变的指标     

Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis

Involvement of granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) in non-lymphohematopoietic malignant tumors accompanied by leukocytosis was clinicopathologically investigated. Among 1,778 autopsy cases in the last 20 years, 485 lesions of 439 cases with non-lymphohematopoietic malignant tumors accompanied by leukocytosis with a white blood cell count of 10,000/mm3 or greater during the course were immunohistologically examined for G-CSF and GM-CSF. Three (0.7%) and two cases (0.5%) were G-CSF- and GM-CSF-positive, respectively. GM-CSF mRNA was confirmed by using non-fixed cryopreserved tumor tissues in one case positive for GM-CSF. G-CSF-positive cases were large cell carcinoma of the lung, adenocarcinoma of the colon, and adenocarcinoma of the stomach, and GM-CSF-positive cases were spindle cell carcinoma of the lung and malignant thymoma. In the case with stomach carcinoma, the primary lesion showing moderately differentiated adenocarcinoma was negative, but the lung metastatic lesion showing less differentiated adenocarcinoma was G-CSF-positive. The survival period was six months or less in four out of five positive cases. The highest white blood cell count in five CSF-positive cases was markedly elevated: 29,400-103,500/mm3 (mean: 59,700/mm3). In four cases, excluding one case which may have been markedly affected by chemotherapy, the bone marrow showed hyperplasia, and the number of the granulocyte series cells significantly increased. There were three cases (0.7%) negative for both G-CSF and GM-CSF, although they showed marked leukocytosis (60,000/mm3 or higher) which were higher than the mean count of CSF-positive cases and was not observed in autopsy cases with non-tumorous diseases. Other stimulating factors may be involved in the development of leukocytosis in such cases.     

Immunohistochemical studies of colorectal carcinoma with a monoclonal antibody against carcinoembryonic antigen

Immunoperoxidase localization of carcinoembryonic antigen (CEA) was performed on tissue sections of colorectal carcinoma using a monoclonal antibody (MAb) against CEA. CEA has been demonstrated in 20 out of 22 rectum carcinomas (90.9%), in all of 23 colonic carcinomas, in none of 4 hyperplastic polyps and in 2 out of 6 adenomatous polyps (33.3%). CEA was found more often, and the intensity of the staining was stronger in well-differentiated carcinomas than in moderately and poorly differentiated carcinomas. No correlation was found between the presence of CEA in colorectal carcinoma and the stages of the disease. The mean values of serum CEA in patients with colorectal carcinoma and polyps with negative, weakly and strongly positive staining were 5.4 +/- 3.9 ng/ml, 28.3 +/- 23.8 ng/ml and 99.8 +/- 145.3 ng/ml respectively. Elevation of serum CEA occurred in 30 out of 39 (78.9%) cases with strongly positive CEA staining, in 4 out of 6 (66.7%) with weakly positive and in 1 out 9 (11.1%) with negative staining. A significant difference was found in serum CEA activity between the group with negative CEA staining and positive CEA staining (P less than 0.01). Our results suggest that the monoclonal antibody (MAb C27) can be used for the localization of CEA in conventionally prepared tissues of colorectal carcinomas by immunoperoxidase techniques for routine immunopathological diagnosis.     

AnnexinⅠ蛋白在人前列腺癌中的表达及临床意义

目的：探讨AnnexinⅠ蛋白在前列腺癌组织中的表达及其与前列腺癌发生、发展、转移及预后的关系。方法：回顾性分析110例前列腺癌及40例前列腺增生组织中AnnexinⅠ蛋白的表达与前列腺癌Gleason分级、年龄、临床分期、转移及预后的相关性。结果：前列腺癌患者的AnnexinⅠ表达水平显著地低于良性前列腺增生症患者（P〈0．05）;AnnexinⅠ在低分化癌中表达较高,与高、中分化癌相比有显著性差异（P〈0．05）;而高、中分化癌之间AnnexinⅠ表达均较低,两者之间无显著性差异（P〉0．05）。前列腺癌AnnexinⅠ蛋白表达与年龄无关,而与临床分期、淋巴结转移及预后有关（P〈0．05）。结论：AnnexinⅠ蛋白表达下调与前列腺癌发生发展和预后密切相关,可作为反映前列腺癌生物学行为和判断预后的生物标记物.     

The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma

Summary Human gastrectomy specimens, including 48 carcinomas and 25 selected benign cases showing extensive intestinal metaplasia (IM), were examined in detail histologically and histochemically. IM was classified into complete (type I), incomplete without sulphomucins (type IIA) and incomplete with sulphomucins (type IIB). Type IIB was associated with intestinal but not diffuse cancers (P<0.01) or benign lesions (P<0.01). The mucin profiles of IIB IM were similar to intestinal cancers with sulphomucins predominating overN-acetylsialomucins.O-acetylsialomucins were not seen in IIB IM or tumours but were observed in complete or type IIM. These findings suggest a histogenic link between incomplete IM secreting sulphomucins (or colonic metaplasia) and intestinal cancers of the human stomach.